共 124 条
[21]
Gunther A(2015)Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia? Expert Opin Pharmacother 16 999-4167
[22]
Mahajan NP(2015)ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers Oncogene 34 4162-22122
[23]
Heinzel T(2012)Ack1-mediated androgen receptor phosphorylation modulates radiation resistance in castration-resistant prostate cancer J Biol Chem 287 22112-28191
[24]
Krämer OH(2014)ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1 J Biol Chem 289 28179-1790
[25]
Chan D(2013)Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML N Engl J Med 368 1781-138
[26]
Cheriyath V(2016)Identification and characterization of tyrosine kinase nonreceptor 2 mutations in leukemia through integration of kinase inhibitor screening and genomic analysis Cancer Res 76 127-566
[27]
Kuhns MA(2014)Autophagy and apoptosis: Where do they meet? Apoptosis Int J Program Cell Death 19 555-228
[28]
Kalaycio ME(2010)Inhibitors of HDACs—Effective drugs against cancer? Curr Cancer Drug Targets 10 210-2721
[29]
Borden EC(2013)Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificities Mol Cancer Ther 12 2709-3143
[30]
Corey EJ(2015)Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach Blood 125 3133-282